Clonazepam disposition in pediatric patients

Therapeutic Drug Monitoring

Volumn 18, Issue 1, 1996, Pages 1-5

  Walson, Philip D ^a,b   Edge, James H ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Clonazepam; Genetics; Nitroreduction

Indexed keywords

7 ACETAMIDOCLONAZEPAM; 7 AMINOCLONAZEPAM; CLONAZEPAM; DRUG METABOLITE; FLUNITRAZEPAM; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACETYLATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISPOSITION; DRUG METABOLISM; EPILEPSY; FEMALE; GENETIC REGULATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REDUCTION;

ACETYLATION; ADOLESCENT; ANTICONVULSANTS; BIOTRANSFORMATION; CHILD; CHILD, PRESCHOOL; CLONAZEPAM; EPILEPSY; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION;

EID: 0030066180     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199602000-00001     Document Type: Article

References (16)

1. Sjo O, Hvidberg EF, Naestoft J, Lund M. Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man. Eur J Clin Pharmacol 1975;8:249-54.
2. Min BH, Garland WA. Determination of clonazepam and its 7-amino metabolite in plasma and blood by gas chromatography-chemical ionization mass spectrometry. J Chromatogr 1977;139:121-33.
3. Berlin A, Dahlstrom H. Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration. Eur J Clin Pharmacol 1975;9:155-9.
4. Edge JH, Walson PD, Rane A. Clonazepam and 7-aminoclonazepam in human plasma. Ther Drug Monit 1991;13: 363-8.
5. Peng D-R, Petters I, Rane A. Nitroreduction of clonazepam in human foetal liver microsomes and hepatocyte cultures. Biochem Soc Trans 1984;12:39-42.
6. Aufrere MB, Hoener B-A, Vore M. Reductive metabolism of nitrofurantion in the rat. Drug Metab Dispos 1978;6:403-11.
7. Rowland M, Tozer TN. Clinical pharmacokinetics, concepts and applications. Philadelphia: Lea & Febiger, 1980:288-9.
8. Eschenhof E. Untersuchungen uber das Schicksal des Antikonvulsivums Clonazepam im Organismus der Ratte, des Hundes und des Menschen. Arzneimittelforschung 1973;23: 390-9.
9. Knop HJ, van der Kleijn E, Edmunds LC. Pharmacokinetics of clonazepam in man and laboratory animals. In: Schneider H, Janz D, Gardner-Thorpe C, Meinardi H, Sherwin AL, eds. Clinical pharmacology of anti-epileptic drugs. New York: Springer-Verlag, 1975:247-59.
10. Dreifuss FE, Penry JK, Rose SW, Kupferberg HJ, Dyken P, Sato S. Serum clonazepam concentrations in children with absence seizures. Neurology 1975;25:255-8.
11. Kaplan SA, Alexander K, Jack ML, et al. Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog. J Pharm Sci 1974;63:527-32.
12. de Silva JAF, Puglisi CV, Munno N. Determination of clonazepam and flunitrazepam in blood and urine by electron-capture GLC. J Pharm Sci 1974;63:520-7.
13. de Silva JAF, Bekersky I. Determination of clonazepam and flunitrazepam in blood by electron-capture gas-liquid chromatography. J Chromatogr 1974;99:447-60.
14. Knop HJ, van der Kleijn E, Edmunds LC. The determination of clonazepam in plasma by gas-liquid chromatography. Pharm Weekbl 1975;110:297-309.
15. Kergueris MF, Bourin M, Larousse C. Pharmacokinetics of isoniazid: influence of age. Eur J Clin Pharmacol 1986;30: 335-40.
16. Endrenyi L, Inaba T, Kalow W. Genetic study of amobarbital elimination based on its kinetics in twins. Clin Pharmacol Ther 1976;20:701-14.